Scientific knowledge has immensely helped in combating the dreadful coronavirus and its spread. Within a record short period of time, scientists (including virologists, epidemiologists, biostatisticians, etc.) and their research outputs helped the commoners to learn more about the SARS-CoV-2 and how it spreads from one individual to the next one. Common people have now come to know how simple techniques and behavioural change like the wearing of N95 masks, maintaining...

-The Hindu There are recognised ways to overcome the patents hurdle, ensuring social justice and boosting the COVID-19 battle In order to achieve global herd immunity and prevent new strains of COVID-19 from emerging, possibly for years to come, vaccines need to be affordable and available in massive quantities throughout the globe. This can happen through patent owners voluntarily licensing their products to other companies, especially Indian producers who are experienced at...

-The Indian Express Innovation in vaccine production can have an impact only if it is accessible to all. Patents and access to life-saving drugs has always been an emotive and contentious issue. The right to healthy life is a moral minimum, and to find a rational basis to deny it is deeply offensive to the idea of life itself. At the same time, pharma corporations and institutions claim patents are a just...

-The Hindu Business Line WTO has allowed countries to issue compulsory licenses during emergencies A Division Bench of the Kerala High Court on Tuesday asked the Centre to respond to a plea for invoking the compulsory licensing to allow other capable vaccine manufacturers to produce Covid vaccines. The Bench comprising Justice Raja Vijayaraghavan and Justice M.R.Anitha passed the directive when a public interest litigation in this regard came up for hearing. The petition...

-The Hindu The U.S.-supported move will have an effect if countries simultaneously address non-IP bottlenecks among other things The United States has finally relented and declared its support for a temporary waiver of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement for COVID-19 vaccines at the World Trade Organisation (WTO). In October 2020, India and South Africa, at the WTO, proposed waiving Sections 1, 4, 5, and 7 of Part II...